asa guidelines for glp-1 Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement GLP-1 medications safe to continue

Khavinson bioregulators, with decades of research behind them, are designed to be taken as capsules or sublingual formulations

Gene expression studies confirm direct effects on pathways controlling hair growth, and the combination of preclinical efficacy plus clinical success in topical applications supports the rationale for injectable use

CJC-1295 with DAC Long duration of activity Fewer injections Continuous growth hormone stimulation CJC-1295 without DAC Shorter duration More dosing flexibility Greater control of timing Patients often use CJC-1295 to support: Lean muscle development Tissue repair and recovery Skin quality and collagen support Long-term metabolic and anti-aging goals CJC-1295 raises IGF-1 levels, which plays a key role in cellular repair and body composition

doi:10.1182/blood-2008-03-040253